HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vincenzo Valentini Selected Research

Gefitinib (Iressa)

3/2018Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up.
1/2014Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line.
11/2008Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092).
10/2004Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 ('Iressa') induces cell-cycle arrest and inhibits proliferation in prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vincenzo Valentini Research Topics

Disease

129Neoplasms (Cancer)
11/2023 - 02/2002
90Rectal Neoplasms (Rectal Cancer)
03/2024 - 07/2002
36Neoplasm Metastasis (Metastasis)
03/2023 - 02/2003
28Breast Neoplasms (Breast Cancer)
10/2022 - 04/2004
28Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 07/2002
24Carcinoma (Carcinomatosis)
01/2023 - 07/2002
22Prostatic Neoplasms (Prostate Cancer)
02/2024 - 07/2002
18Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023 - 07/2005
15Adenocarcinoma
01/2022 - 10/2007
12Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 02/2010
10Pain (Aches)
03/2023 - 01/2003
9COVID-19
01/2024 - 01/2020
9Endometrial Neoplasms (Endometrial Cancer)
11/2022 - 05/2005
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 11/2007
8Pathologic Complete Response
01/2023 - 06/2008
8Squamous Cell Carcinoma of Head and Neck
09/2022 - 09/2009
8Melanoma (Melanoma, Malignant)
01/2022 - 03/2015
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2002
5Lung Neoplasms (Lung Cancer)
11/2023 - 02/2010
5Skin Neoplasms (Skin Cancer)
07/2021 - 03/2015
5Glioblastoma (Glioblastoma Multiforme)
01/2020 - 05/2010
5Colorectal Neoplasms (Colorectal Cancer)
03/2016 - 09/2013
5Stomach Neoplasms (Stomach Cancer)
01/2015 - 07/2003
4Anus Neoplasms (Anal Cancer)
11/2023 - 05/2005
4Residual Neoplasm
08/2022 - 03/2010
4Sarcoma (Soft Tissue Sarcoma)
08/2020 - 03/2011
4Cholangiocarcinoma
06/2020 - 04/2014
4Brain Neoplasms (Brain Tumor)
01/2017 - 11/2012
3Infections
01/2024 - 08/2014
3Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
10/2023 - 11/2012
3Pelvic Neoplasms
01/2023 - 08/2012
3Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 10/2016
3AIDS-Related Complex (ARC)
01/2021 - 01/2017
3Colonic Neoplasms (Colon Cancer)
01/2020 - 09/2013
3Uveal melanoma
02/2019 - 12/2017
3Hemorrhage
01/2016 - 06/2012
3Disease Progression
03/2010 - 01/2004
2Lymphoma (Lymphomas)
10/2023 - 10/2020
2Ventricular Tachycardia
01/2023 - 01/2022
2Frailty
11/2022 - 09/2022
2Paraneoplastic Syndromes (Paraneoplastic Syndrome)
01/2021 - 07/2020
2Hypertension (High Blood Pressure)
01/2020 - 08/2009
2Pathologic Constriction (Stenosis)
08/2018 - 05/2005
2Macular Degeneration (Age-Related Maculopathy)
03/2018 - 12/2017
2Deglutition Disorders (Dysphagia)
10/2016 - 01/2016
2Uterine Neoplasms (Uterine Cancer)
05/2016 - 03/2011

Drug/Important Bio-Agent (IBA)

14Fluorouracil (Carac)FDA LinkGeneric
03/2018 - 07/2002
6Biomarkers (Surrogate Marker)IBA
06/2023 - 06/2012
6Cetuximab (Erbitux)FDA Link
09/2022 - 03/2011
6Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 09/2004
6Temozolomide (Temodar)FDA LinkGeneric
10/2020 - 03/2010
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 07/2002
5Hormones (Hormone)IBA
01/2020 - 03/2004
5raltitrexed (D 1694)IBA
10/2012 - 09/2004
4Analgesics (Analgesic Drugs)IBA
11/2022 - 01/2003
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2020 - 04/2012
4Gefitinib (Iressa)FDA Link
03/2018 - 10/2004
4ErbB Receptors (EGF Receptor)IBA
04/2015 - 10/2004
4Mitomycin (Mitomycin-C)FDA LinkGeneric
07/2005 - 07/2002
3Hemoglobins (Hemoglobin)IBA
11/2023 - 02/2003
3AndrogensIBA
01/2020 - 10/2004
3Capecitabine (Xeloda)FDA Link
01/2019 - 05/2010
3GemcitabineFDA Link
02/2016 - 03/2010
3Biological FactorsIBA
07/2002 - 07/2002
2C-Reactive ProteinIBA
04/2022 - 10/2021
2NAD (NADH)IBA
01/2022 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2017
2Ruthenium-106IBA
03/2018 - 12/2017
2Bevacizumab (Avastin)FDA Link
03/2016 - 12/2014
2Leucovorin (Folinic Acid)FDA Link
11/2014 - 03/2003
2Docetaxel (Taxotere)FDA Link
10/2014 - 01/2012
2AnthracyclinesIBA
10/2014 - 01/2012

Therapy/Procedure

241Radiotherapy
03/2024 - 01/2002
63Therapeutics
10/2023 - 02/2002
50Drug Therapy (Chemotherapy)
03/2024 - 01/2003
49Neoadjuvant Therapy
02/2024 - 02/2002
39Chemoradiotherapy
02/2024 - 03/2003
36Brachytherapy
02/2024 - 05/2005
25Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2023 - 04/2010
11Adjuvant Chemotherapy
01/2019 - 03/2003
10Adjuvant Radiotherapy
01/2021 - 01/2002
9Palliative Care (Palliative Therapy)
03/2023 - 08/2012
8Combined Modality Therapy
12/2021 - 01/2003
5Precision Medicine
11/2023 - 07/2014
5Prostatectomy (Retropubic Prostatectomy)
11/2018 - 07/2002
5Conformal Radiotherapy
03/2011 - 08/2009
5Proctectomy
03/2007 - 07/2002
4Laryngectomy
09/2022 - 09/2009
3Immunotherapy
01/2022 - 06/2020
3Lymph Node Excision (Lymph Node Dissection)
08/2018 - 04/2004
2Re-Irradiation
05/2023 - 02/2019
2Radiofrequency Ablation
01/2022 - 07/2021
2Contraindications
01/2022 - 01/2003
2Particle Accelerators
01/2022 - 01/2017
2Colostomy
05/2021 - 01/2016
2Mammaplasty (Breast Reconstruction)
07/2020 - 11/2016
2Mastectomy (Mammectomy)
07/2020 - 11/2016
2Retreatment
10/2019 - 11/2017
2Image-Guided Radiotherapy
01/2015 - 01/2008
2Operative Surgical Procedures
01/2015 - 07/2002